메뉴 건너뛰기




Volumn 10, Issue 2, 2003, Pages 137-141

Predicting coronary risk in the general population – is it necessary to measure high-density lipoprotein cholesterol?

Author keywords

cholesterol; epidemiology; mass screening; primary prevention; risk assessment

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

EID: 0037396684     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/174182670301000209     Document Type: Article
Times cited : (8)

References (15)
  • 2
    • 0032437504 scopus 로고    scopus 로고
    • Joint British Recommendations on prevention of coronary heart disease in clinical practice
    • Wood D, Durrington P, Poulter N, McInnes G, Rees A, Wray R. Joint British Recommendations on prevention of coronary heart disease in clinical practice. Heart 1998; 80 S2: 1–29.
    • (1998) Heart , vol.80 , Issue.S2 , pp. 1-29
    • Wood, D.1    Durrington, P.2    Poulter, N.3    McInnes, G.4    Rees, A.5    Wray, R.6
  • 3
    • 0032874699 scopus 로고    scopus 로고
    • Guidelines for management of hypertension: Report of the third working party of the British Hypertension Society
    • Ramsay LE, Williams B, Johnston GD, MacGregor GA, Poston L, Potter JF, et al Guidelines for management of hypertension: Report of the third working party of the British Hypertension Society. J Hum Hypertens 1999; 13: 569–592.
    • (1999) J Hum Hypertens , vol.13 , pp. 569-592
    • Ramsay, L.E.1    Williams, B.2    Johnston, G.D.3    MacGregor, G.A.4    Poston, L.5    Potter, J.F.6
  • 4
    • 0025959101 scopus 로고
    • An updated coronary risk profile: A statement for health professionals
    • Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile: A statement for health professionals. Circulation 1991; 83: 356–362.
    • (1991) Circulation , vol.83 , pp. 356-362
    • Anderson, K.M.1    Wilson, P.W.F.2    Odell, P.M.3    Kannel, W.B.4
  • 5
    • 0034635906 scopus 로고    scopus 로고
    • Updated New Zealand cardiovascular disease risk-benefit prediction guide
    • Jackson R. Updated New Zealand cardiovascular disease risk-benefit prediction guide. BMJ 2000; 320: 709–710.
    • (2000) BMJ , vol.320 , pp. 709-710
    • Jackson, R.1
  • 6
    • 0034635863 scopus 로고    scopus 로고
    • Coronary and cardiovascular risk estimation for primary prevention: Validation of new Sheffield table in the 1995 Scottish health survey population
    • Wallis EJ. Coronary and cardiovascular risk estimation for primary prevention: Validation of new Sheffield table in the 1995 Scottish health survey population. BMJ 2000; 320: 671–676.
    • (2000) BMJ , vol.320 , pp. 671-676
    • Wallis, E.J.1
  • 7
    • 0003531808 scopus 로고    scopus 로고
    • London: British Medical Association; March
    • British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary 41. London: British Medical Association; March 2001.
    • (2001) British National Formulary 41
  • 9
    • 0032987038 scopus 로고    scopus 로고
    • Indications for cholesterol-lowering medication: Comparison of risk-assessment methods
    • Durrington PN, Prais H, France M, Crowley V, Khan J, Morgan J. Indications for cholesterol-lowering medication: Comparison of risk-assessment methods. Lancet 1999; 353: 278–281.
    • (1999) Lancet , vol.353 , pp. 278-281
    • Durrington, P.N.1    Prais, H.2    France, M.3    Crowley, V.4    Khan, J.5    Morgan, J.6
  • 12
    • 0031753938 scopus 로고    scopus 로고
    • Ischemic heart disease and stroke mortality in African-American, Hispanic and non-Hispanic white men and women, 1985–1991
    • Karter AJ, Gazzaniga JM, Cohen RD, Casper ML, Davis BD, Kaplan GA. Ischemic heart disease and stroke mortality in African-American, Hispanic and non-Hispanic white men and women, 1985–1991. West J Med 1998; 169: 139–145.
    • (1998) West J Med , vol.169 , pp. 139-145
    • Karter, A.J.1    Gazzaniga, J.M.2    Cohen, R.D.3    Casper, M.L.4    Davis, B.D.5    Kaplan, G.A.6
  • 13
    • 0032996943 scopus 로고    scopus 로고
    • Is the Framingham risk function valid for Northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men
    • Haq IU, Ramsay LE, Yeo WW, Jackson PR, Wallis EJ. Is the Framingham risk function valid for Northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart 1999; 81: 40–46.
    • (1999) Heart , vol.81 , pp. 40-46
    • Haq, I.U.1    Ramsay, L.E.2    Yeo, W.W.3    Jackson, P.R.4    Wallis, E.J.5
  • 14
    • 0030710191 scopus 로고    scopus 로고
    • Prediction of coronary heart disease mortality in Busselton, Western Australia; an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores
    • Knuiman MW, Vu H.T.V. Prediction of coronary heart disease mortality in Busselton, Western Australia; an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores. J Epidemiol Community Health 1997; 51: 515–519.
    • (1997) J Epidemiol Community Health , vol.51 , pp. 515-519
    • Knuiman, M.W.1    Vu, H.T.V.2
  • 15
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the hypertension optimal treatment (HOT) randomised trial
    • Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the hypertension optimal treatment (HOT) randomised trial. Lancet 1998; 351: 1755–1762.
    • (1998) Lancet , vol.351 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3    Dahlof, B.4    Elmfeldt, D.5    Julius, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.